Obesity giant Novo Nordisk misses forecasts and lowers profit outlook
Wegovy sales come up shortOperating profit guidance loweredRevenue guidance raisedDanish weight-loss drug maker Novo Nordisk (NOVO-B:CPH) suffered a rare setback as its second-quarter operating profit missed expectations and it cut...
07 August 2024